In vitro diagnostics are tests that can detect diseases, conditions, or infections. Some tests are used in laboratory or other health professional settings and other tests are for consumers to use at home.
According to Japan's pharmaceutical Affairs law, In-Vitro Diagnostics is defined as "medical product not administered directly to humans or animals of medicinal products used solely to diagnose disease." Therefore, In-Vitro Diagnostics are legally classified as medicinal product and strict rules must be observed when developing, manufacturing and controlling the same. Therefore the threshold of obtaining the certification is keep new competitors from entering the market.
In-Vitro Diagnostics is a good investment choice. However, disadvantage factors and threat such as serious competition should be considered.
According to this study, over the next five years the In-Vitro Diagnostics market will register a 4.5% CAGR in terms of revenue, the global market size will reach US$ 70000 million by 2024, from US$ 53900 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in In-Vitro Diagnostics business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of In-Vitro Diagnostics market by product type, application, key manufacturers and key regions and countries.
This study considers the In-Vitro Diagnostics value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3: and forecast to 2024 in section 11.7.
Tissue diagnostics
Professional diagnostic
Molecular diagnostic
Diabetes Monitoring
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4: and forecast to 2024 in section 11.8.
Diabetes
Infectious Diseases
Oncology
Cardiology
HIV
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Siemens Healthcare
Johnson and Johnson
Becton Dickinson
Abbott Laboratories
Roche Diagnostics
Beckman Coulter Inc
Thermo Scientific
Cobas
Caprion
Merck Millipore
Aptiv Solution
Danaher Corporation
Biomerieux
Bio-Rad Laboratories
Ortho Clinical Diagnostics
Sysmex Corporation
Mindray
Shanghai Kehua Bio-engineering
BioSino Bio-technology
Beijing Leadman Biochemistry
DAAN Gene
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global In-Vitro Diagnostics consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of In-Vitro Diagnostics market by identifying its various subsegments.
Focuses on the key global In-Vitro Diagnostics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the In-Vitro Diagnostics with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of In-Vitro Diagnostics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
